|
|
|
|
|
|
Category List
|
 |
|
|
|
|
|
Video Links
|
 |
|
|
|
|
|
Partners
|
 |
|

Proceeds from Life Science: China go to support the charitable activities of the Cheng Health Foundation.
www.chenghealth.org
|
|
|
|
|
Video Lists
|
 |
|
|
|
 | | World Economic Forum Dalian: IP Protection in China | | The Myths and Realities of IPR Protection in China
Feng Jun, Chairman, Beijing Huaqi Information Digital Technology, PRC
Greg Shea, President and Managing Director, US Information Technology Office, PRC
Tian Lipu, Minister of State, Intellectual Property Office, PRC
Hiroshi Tsukamoto, President, Japan External Trade Organization (JETRO), Japan
Zhiguo Xiao, CEO and Chairman of the Board, Luming Science & Technology Group Co., PRC
Chaired by Thomas Easton, Asia Business Editor, The Economist, Hong Kong SAR Sept. 2007 | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:17 | | | |
 | | Davos 2007: Asia's New Business Giants | | What's on the Mind of Asia's New Business Giants?
Chinese and Indian business leaders are reshaping industrial sectors while creating a new dynamic in the global competitive landscape.
Richard S. Fuld Jr, Chairman and Chief Executive Officer, Lehman Brothers, USA
Nandan M. Nilekani, Chief Executive Officer and Managing Director, Infosys Technologies, India;
Azim H. Premji, Chairman, Wipro, India
Edward S. Tian, Vice-Chairman, China Netcom (Group) Company, People's Republic of China
Chaired by Maria Bartiromo. July 2007 | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:18 | | | |
 | | Michael Hui, Founder of Shanghai ChemPartner | | Shanghai ChemPartner Co., Ltd. is an R&D contract research company providing customized services to international pharmaceutical, biotech, agrochemical, and chemical companies. ChemPartner currently has a team of more than 250 scientists, including more than 40 PhDs, who either had extensive ovesea R&D experiences in pharmaceutical / biotech companies, universities, or were trained at top chemistry research institutes in China before joining ChemPartner. www.chempartner.cn | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:331 | | | |
 | | Dr. Samantha Du, Hutchison MediPharma | | Dr. Du is the Managing Director of Hutchison Medipharma Limited; Chief Scientific Officer and Executive Vice President of Hutchison Chi-Med. Hutchisong Chi-Med trades on the LSE AIM (HCM). HMPL has a fully integrated drug discovery and development infrastructure, cutting-edge drug discovery platforms, and an experienced senior management team drawn largely from leading pharmaceutical and biotechnology companies. www.hmplglobal.com
| | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:154 | | | |
 | | Dr. Ying Luo, President of Shanghai Genomics | | Shanghai Genomics dedicates itself in developing novel therapeutic products in lung fibrosis, hepatocirrhosis, viral infection, and new biomaterials for fractured bone rehabilitation. They also provide biotechnology services and products to worldwide research institutes, hospitals and companies. The company currently employs 93 people, including 14 Ph.D. scientists in a 32,000-square-foot building located in Shanghai. www.shanghaigenomics.com | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:47 | | | |
 | | Dr. Chunlin Chen, President & CEO Medicilon | | Medicilon offers integrated pharmaceutical services designed to drug discovery and development efforts.
Medicilon was founded in 2003 to provide custom drug discovery services to the
pharmaceutical and biotech community. The company is located in the Zhangjiang Hi-
Tech Park in Shanghai, China and occupies 85,000 square feet of R&D facilities with
250+ scientists.
www.medicilon.com | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:34 | | | |
 | | Dr Lingshi Tan, Pfizer (China) Research & Development Co., Ltd | | Dr. Lingshi Tan is the General Manager of Pfizer (China) Research and Development Co., Ltd. It's R&D Centre is engaged in drug development activities including study design, data management and statistical analysis of global phase I-IV clinical trials. The centre will also train Pfizer employees in China and throughout the region in internationally recognized Good Clinical Practice standards.
October 31, 2005 | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:85 | | | |
 | | Dr. Xiaochuan Wang, Chairman & CEO of Sundia Meditech | | Dr. Xiaochuan Wang discusses the founding and current operations of Sundia Meditech. Sundia Meditech is a Shanghai based CRO company providing drug discovery & development services to worldwide clients.
www.sundia.com | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:45 | | | |
 | | World Economic Forum interview with Victor Chu | | World Economic Forum interview with Victor Chu, Chairman and CEO, First Eastern Investment Group. Mr Chu talks about the Forum's new Community of Global Growth Companies and the Inaugural Annual Meeting of the New Champions, 6-8 September 2007. | | | Added:2 years ago, in category:CEO INTERVIEWS | | From: | | Comments:0 / Views:8 | | | |
|
|
|
|
|
|
|
The information on this website is provided for educational and entertainment purposes only. The information presented is obtained from public sources that are deemed reliable, however no warranty as to the accuracy of the data is expressed or implied. Opinions expressed in any video or other linked content are those of the content producers and do not reflect the opinions of Life Science: China or the Cheng Health Foundation, Inc.
Many of these companies can be classified as MICROCAP companies, implying they may have LIMITED LIQUIDITY and be considered HIGH RISK. Individual DUE DILIGENCE is required. Under no circumstances does the information in this website represent a recommendation to buy or sell stocks.
This site is operated under license to HG Pacific Management, LLC. Unless otherwise indicated, the material of this site is © 2007 Cheng Health Foundation, Inc. All Rights Reserved. Life Science: China ® Cheng Health Foundation, Inc.
|
 |
|
 |
|
|
|
|
|